English

Clovis Oncology, Inc.

EDGAR

CLVS Quarterly report (10-Q) · filed 2022-11-09

55 filing records in this dataset, filed from 2011-06-23 to 2022-11-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

30.7 million Unit_Standard_USD_CCZDFU9HPUiY83DiASVg2A

2022 Q3 · Unit_Standard_USD_CCZDFU9HPUiY83DiASVg2A

Exact inputs and evidence

Revenue: 30663000 Unit_Standard_USD_CCZDFU9HPUiY83DiASVg2A Source

Operating margin

-144.26%

2022 Q3 · %

Exact inputs and evidence

Operating Income: -44235000 Unit_Standard_USD_CCZDFU9HPUiY83DiASVg2A Source
Revenue: 30663000 Unit_Standard_USD_CCZDFU9HPUiY83DiASVg2A Source

Cash and cash equivalents: 58.3 million Unit_Standard_USD_CCZDFU9HPUiY83DiASVg2A 2022-09-30 Source
Exact value

58320000 Unit_Standard_USD_CCZDFU9HPUiY83DiASVg2A
Long-term debt including current maturities: 443 million Unit_Standard_USD_CCZDFU9HPUiY83DiASVg2A 2022-09-30 Source
Exact value

443282000 Unit_Standard_USD_CCZDFU9HPUiY83DiASVg2A
Shares outstanding: 145 million Unit_Standard_shares_Q0xrwCuWNUauACLAJbXMug 2022-09-30 Source
Exact value

144804422 Unit_Standard_shares_Q0xrwCuWNUauACLAJbXMug

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-11-09.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2021-12-31
Operating income: 3 of 11 periods available· newest 2021-12-31
Net income: 3 of 11 periods available· newest 2021-12-31
Operating cash flow: 3 of 11 periods available· newest 2021-12-31
Capital expenditure: 3 of 11 periods available· newest 2021-12-31
Total assets: Multiple units; comparison withheld· newest 2021-12-31
Total liabilities: Multiple units; comparison withheld· newest 2021-12-31
Current assets: Multiple units; comparison withheld· newest 2021-12-31
Current liabilities: Multiple units; comparison withheld· newest 2021-12-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2021-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2018-12-31
Shares outstanding: Multiple units; comparison withheld· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-9.6%

Prior period

Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 164.52 million

2020-01-01 – 2020-12-31
Current period

Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 148.76 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

148757000 − 164522000 = -15765000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg

164522000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
148757000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Clovis Oncology, Inc. · 2021-12-31 Clovis Oncology, Inc. (edgar:1466301) Year-over-year change in Revenue: -15765000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 148757000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#3625589 Filing: 000155837022001810 Input fundies:Revenue: 164522000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#3629071 Filing: 000155837022001810
The citation records this snapshot. The page link may show a newer release later.
Net income
+Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 104.69 million

Prior period

−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 369.21 million

2020-01-01 – 2020-12-31
Current period

−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 264.52 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-264524000 − -369212000 = 104688000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg

-369212000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-264524000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Clovis Oncology, Inc. · 2021-12-31 Clovis Oncology, Inc. (edgar:1466301) Year-over-year change in Net income: 104688000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -264524000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#3823713 Filing: 000155837022001810 Input fundies:NetIncome: -369212000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#3826759 Filing: 000155837022001810
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 56.67 million

Prior period

−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 252.73 million

2020-01-01 – 2020-12-31
Current period

−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 196.06 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-196057000 − -252728000 = 56671000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg

-252728000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-196057000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Clovis Oncology, Inc. · 2021-12-31 Clovis Oncology, Inc. (edgar:1466301) Year-over-year change in Operating cash flow: 56671000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -196057000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2352348 Filing: 000155837022001810 Input fundies:OperatingCashFlow: -252728000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2353330 Filing: 000155837022001810
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-11.9%

Prior period

Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 354,000

2020-01-01 – 2020-12-31
Current period

Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 312,000

2021-01-01 – 2021-12-31

Exact inputs and evidence

312000 − 354000 = -42000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg

354000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
312000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Clovis Oncology, Inc. · 2021-12-31 Clovis Oncology, Inc. (edgar:1466301) Year-over-year change in Capital expenditure: -42000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 312000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2358514 Filing: 000155837022001810 Input fundies:CapitalExpenditure: 354000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2359483 Filing: 000155837022001810
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 148.76 million 100% of revenue
Operating costs Derived Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 374.52 million 252% of revenue
Operating income −Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 225.77 million −152% of revenue
Tax, interest and other Derived Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 38.76 million 26% of revenue
Net income −Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 264.52 million −178% of revenue

Cash

Operating cash flow −Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 196.06 million −132% of revenue
Capital expenditure Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 312,000 0.2% of revenue
Free cash flow Derived −Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 196.37 million −132% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Operating loss: operating costs were 363% of revenue.
2020 Operating loss: operating costs were 284% of revenue.
2021 Operating loss: operating costs were 252% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	143006000	519752000 Derived	-376746000	23678000 Derived	-400424000	-326905000 Derived	Source 2019-01-01 – 2019-12-31: 143006000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Revenue Open source 2019-01-01 – 2019-12-31: -376746000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -400424000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Net Income Open source 2019-01-01 – 2019-12-31: -323615000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 3290000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	164522000	466710000 Derived	-302188000	67024000 Derived	-369212000	-253082000 Derived	Source 2020-01-01 – 2020-12-31: 164522000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Revenue Open source 2020-01-01 – 2020-12-31: -302188000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -369212000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Net Income Open source 2020-01-01 – 2020-12-31: -252728000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 354000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	148757000	374524000 Derived	-225767000	38757000 Derived	-264524000	-196369000 Derived	Source 2021-01-01 – 2021-12-31: 148757000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Revenue Open source 2021-01-01 – 2021-12-31: -225767000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -264524000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Net Income Open source 2021-01-01 – 2021-12-31: -196057000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 312000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Capital Expenditure Open source

Amounts are exact, in Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 148.8M 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg)	Source evidence
20192019-12-31	Revenue	143006000	Revenue: 143006000 Open source
20202020-12-31	Revenue	164522000	Revenue: 164522000 Open source
20212021-12-31	Revenue	148757000	Revenue: 148757000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-9.6% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 143006000 Open source
20202020-12-31	Year over year	15%	Revenue: 164522000 Open source Revenue: 143006000 Open source
20212021-12-31	Year over year	-9.6%	Revenue: 148757000 Open source Revenue: 164522000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -151.8% 2021

Net margin -177.8% 2021

Free cash flow margin -132% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	-263.4%	Operating Income: -376746000 Open source Revenue: 143006000 Open source
20202020-12-31	Operating margin	-183.7%	Operating Income: -302188000 Open source Revenue: 164522000 Open source
20212021-12-31	Operating margin	-151.8%	Operating Income: -225767000 Open source Revenue: 148757000 Open source
20192019-12-31	Net margin	-280%	Net Income: -400424000 Open source Revenue: 143006000 Open source
20202020-12-31	Net margin	-224.4%	Net Income: -369212000 Open source Revenue: 164522000 Open source
20212021-12-31	Net margin	-177.8%	Net Income: -264524000 Open source Revenue: 148757000 Open source
20192019-12-31	Free cash flow margin	-228.6%	Revenue: 143006000 Open source Operating Cash Flow: -323615000 Open source Capital Expenditure: 3290000 Open source
20202020-12-31	Free cash flow margin	-153.8%	Revenue: 164522000 Open source Operating Cash Flow: -252728000 Open source Capital Expenditure: 354000 Open source
20212021-12-31	Free cash flow margin	-132%	Revenue: 148757000 Open source Operating Cash Flow: -196057000 Open source Capital Expenditure: 312000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg -196.1M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg)	Source evidence
20192019-12-31	Operating cash flow	-323615000	Operating Cash Flow: -323615000 Open source
20202020-12-31	Operating cash flow	-252728000	Operating Cash Flow: -252728000 Open source
20212021-12-31	Operating cash flow	-196057000	Operating Cash Flow: -196057000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg -196.4M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg)	Source evidence
20192019-12-31	Free cash flow	-326905000	Operating Cash Flow: -323615000 Open source Capital Expenditure: 3290000 Open source
20202020-12-31	Free cash flow	-253082000	Operating Cash Flow: -252728000 Open source Capital Expenditure: 354000 Open source
20212021-12-31	Free cash flow	-196369000	Operating Cash Flow: -196057000 Open source Capital Expenditure: 312000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2019-12-31	Liabilities / assets	Not reported	No source recorded
2020-12-31	Liabilities / assets	Not reported	No source recorded
2021-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2019-12-31	Current assets / current liabilities	Not reported	No source recorded
2020-12-31	Current assets / current liabilities	Not reported	No source recorded
2021-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 400.42 million Exact value Exact value: -400424000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2019-01-01 – 2019-12-31: -400424000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Net Income Open source Share or cite Citation for Net Income · Clovis Oncology, Inc. · 2019-12-31 Clovis Oncology, Inc. (edgar:1466301) Net Income: -400424000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg&dimensions= Input fundies:NetIncome: -400424000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#3829806 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 323.62 million Exact value Exact value: -323615000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2019-01-01 – 2019-12-31: -323615000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Clovis Oncology, Inc. · 2019-12-31 Clovis Oncology, Inc. (edgar:1466301) Operating Cash Flow: -323615000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg&dimensions= Input fundies:OperatingCashFlow: -323615000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2354313 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 3.29 million Exact value Exact value: 3290000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2019-01-01 – 2019-12-31: 3290000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Clovis Oncology, Inc. · 2019-12-31 Clovis Oncology, Inc. (edgar:1466301) Capital Expenditure: 3290000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg&dimensions= Input fundies:CapitalExpenditure: 3290000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2360453 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 326.91 million Calculation and evidence -323615000 − 3290000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Exact free cash flow: -326905000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2019-01-01 – 2019-12-31: -323615000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 3290000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Clovis Oncology, Inc. · 2019-12-31 Clovis Oncology, Inc. (edgar:1466301) Free cash flow: -326905000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -323615000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2354313 Filing: 000155837022001810 Input fundies:CapitalExpenditure: 3290000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2360453 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 369.21 million Exact value Exact value: -369212000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2020-01-01 – 2020-12-31: -369212000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Net Income Open source Share or cite Citation for Net Income · Clovis Oncology, Inc. · 2020-12-31 Clovis Oncology, Inc. (edgar:1466301) Net Income: -369212000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg&dimensions= Input fundies:NetIncome: -369212000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#3826759 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 252.73 million Exact value Exact value: -252728000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2020-01-01 – 2020-12-31: -252728000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Clovis Oncology, Inc. · 2020-12-31 Clovis Oncology, Inc. (edgar:1466301) Operating Cash Flow: -252728000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg&dimensions= Input fundies:OperatingCashFlow: -252728000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2353330 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 354,000 Exact value Exact value: 354000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2020-01-01 – 2020-12-31: 354000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Clovis Oncology, Inc. · 2020-12-31 Clovis Oncology, Inc. (edgar:1466301) Capital Expenditure: 354000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg&dimensions= Input fundies:CapitalExpenditure: 354000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2359483 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 253.08 million Calculation and evidence -252728000 − 354000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Exact free cash flow: -253082000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2020-01-01 – 2020-12-31: -252728000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 354000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Clovis Oncology, Inc. · 2020-12-31 Clovis Oncology, Inc. (edgar:1466301) Free cash flow: -253082000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -252728000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2353330 Filing: 000155837022001810 Input fundies:CapitalExpenditure: 354000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2359483 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 264.52 million Exact value Exact value: -264524000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2021-01-01 – 2021-12-31: -264524000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Net Income Open source Share or cite Citation for Net Income · Clovis Oncology, Inc. · 2021-12-31 Clovis Oncology, Inc. (edgar:1466301) Net Income: -264524000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg&dimensions= Input fundies:NetIncome: -264524000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#3823713 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 196.06 million Exact value Exact value: -196057000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2021-01-01 – 2021-12-31: -196057000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Clovis Oncology, Inc. · 2021-12-31 Clovis Oncology, Inc. (edgar:1466301) Operating Cash Flow: -196057000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg&dimensions= Input fundies:OperatingCashFlow: -196057000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2352348 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 312,000 Exact value Exact value: 312000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2021-01-01 – 2021-12-31: 312000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Clovis Oncology, Inc. · 2021-12-31 Clovis Oncology, Inc. (edgar:1466301) Capital Expenditure: 312000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg&dimensions= Input fundies:CapitalExpenditure: 312000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2358514 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.	−Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 196.37 million Calculation and evidence -196057000 − 312000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Exact free cash flow: -196369000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg 2021-01-01 – 2021-12-31: -196057000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 312000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Clovis Oncology, Inc. · 2021-12-31 Clovis Oncology, Inc. (edgar:1466301) Free cash flow: -196369000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:14:45Z Snapshot: 7bf39f5fc48f3917c971846b2fe3549b8561dfcdfce39957b75b2297949ae3b0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1466301?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -196057000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2352348 Filing: 000155837022001810 Input fundies:CapitalExpenditure: 312000 Unit_Standard_USD_EDkfJAu6EUSUareU1TxOgg (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1466301/000155837022001810/clvs-20211231x10k.htm#2358514 Filing: 000155837022001810 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

55 filings · 5,202 latest values · 5,202 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001466301, 1466301, CLVS, edgar:1466301

Also known as CLOVIS ONCOLOGY, INC., Clovis Oncology, Inc., Clovis Oncology, Inc.

Clovis Oncology, Inc.

Latest quarter

Revenue

Operating margin

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation